CHILDREN'S ACUTE HEMATOGENOUS OSTEOMYLITIS: REVIEW ARTICLE | ||||
| Al-Azhar Journal of Pediatrics | ||||
| Article 1, Volume 27, Issue 2, April 2024, Page 3873-3880 PDF (196.59 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/azjp.2024.354180 | ||||
 View on SCiNiTO | ||||
| Abstract | ||||
| The most vascularized areas of the developing skeleton are frequently affected by the common invasive infection known as acute hematogenous osteomyelitis (AHO). This infection mostly affects children and is frequently spread hematogenously. In pediatric patients, the most common cause of acute hematogenous osteomyelitis (AHO) is now Staphylococcus aureus. The patient's age is frequently linked to the particular organism that was discovered in cases of bacterial osteomyelitis. In order to effectively treat pediatric AHO, antibiotic therapy must be initiated early. Parenterally administered antimicrobial drugs, such as vancomycin and clindamycin, must be given for at least four to six weeks. A review of the literature is conducted with regards to the management, symptoms, and etiology of AHO in children. We offer a paradigm for empirical therapy based on published recommendations and the body of relevant literature. Keywords: children, antibiotics, bone infection, pediatric infectious disorders, acute hematogenous osteomylitis | ||||
|
Statistics Article View: 41 PDF Download: 57 |
||||
